Annual CFO
-$60.63 M
+$25.48 M+29.59%
31 December 2023
Summary:
Bicycle Therapeutics annual cash flow from operations is currently -$60.63 million, with the most recent change of +$25.48 million (+29.59%) on 31 December 2023. During the last 3 years, it has fallen by -$45.83 million (-309.81%). BCYC annual CFO is now -4184.66% below its all-time high of -$1.42 million, reached on 31 December 2017.BCYC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$39.83 M
+$4.79 M+10.74%
30 September 2024
Summary:
Bicycle Therapeutics quarterly cash flow from operations is currently -$39.83 million, with the most recent change of +$4.79 million (+10.74%) on 30 September 2024. Over the past year, it has increased by +$7.46 million (+15.77%). BCYC quarterly CFO is now -216.82% below its all-time high of $34.10 million, reached on 30 June 2023.BCYC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$202.62 M
-$38.81 M-23.69%
30 September 2024
Summary:
Bicycle Therapeutics TTM cash flow from operations is currently -$202.62 million, with the most recent change of -$38.81 million (-23.69%) on 30 September 2024. Over the past year, it has dropped by -$141.99 million (-234.20%). BCYC TTM CFO is now -8905.16% below its all-time high of -$2.25 million, reached on 31 March 2020.BCYC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCYC Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +15.8% | -234.2% |
| 3 y3 years | -309.8% | -281.7% | -1269.6% |
| 5 y5 years | -111.9% | -709.8% | -608.1% |
BCYC Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -309.8% | +29.6% | -216.8% | +43.8% | -1269.6% | at low |
| 5 y | 5 years | -309.8% | +29.6% | -216.8% | +43.8% | -8905.2% | at low |
| alltime | all time | -4184.7% | +29.6% | -216.8% | +43.8% | -8905.2% | at low |
Bicycle Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$39.83 M(-10.7%) | -$202.62 M(+23.7%) |
| June 2024 | - | -$44.63 M(-37.0%) | -$163.81 M(+92.5%) |
| Mar 2024 | - | -$70.87 M(+49.9%) | -$85.09 M(+40.3%) |
| Dec 2023 | -$60.63 M(-29.6%) | -$47.29 M(+4513.5%) | -$60.63 M(+38.9%) |
| Sept 2023 | - | -$1.02 M(-103.0%) | -$43.65 M(-10.0%) |
| June 2023 | - | $34.10 M(-173.5%) | -$48.49 M(-54.3%) |
| Mar 2023 | - | -$46.41 M(+53.1%) | -$106.12 M(+23.2%) |
| Dec 2022 | -$86.11 M(+482.1%) | -$30.31 M(+416.2%) | -$86.11 M(+30.0%) |
| Sept 2022 | - | -$5.87 M(-75.0%) | -$66.24 M(+71.4%) |
| June 2022 | - | -$23.53 M(-10.9%) | -$38.65 M(+40.6%) |
| Mar 2022 | - | -$26.40 M(+153.0%) | -$27.49 M(+85.8%) |
| Dec 2021 | -$14.79 M | -$10.44 M(-148.0%) | -$14.79 M(-29.5%) |
| Sept 2021 | - | $21.72 M(-275.6%) | -$20.98 M(-60.2%) |
| June 2021 | - | -$12.37 M(-9.8%) | -$52.68 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$13.71 M(-17.5%) | -$52.66 M(+196.0%) |
| Dec 2020 | -$17.79 M(-37.8%) | -$16.62 M(+66.4%) | -$17.79 M(+192.1%) |
| Sept 2020 | - | -$9.98 M(-19.1%) | -$6.09 M(-12.9%) |
| June 2020 | - | -$12.35 M(-158.4%) | -$6.99 M(+210.7%) |
| Mar 2020 | - | $21.16 M(-530.2%) | -$2.25 M(-92.1%) |
| Dec 2019 | -$28.61 M(+9.7%) | -$4.92 M(-54.8%) | -$28.61 M(-12.1%) |
| Sept 2019 | - | -$10.88 M(+43.1%) | -$32.55 M(+23.7%) |
| June 2019 | - | -$7.61 M(+46.3%) | -$26.32 M(+9.6%) |
| Mar 2019 | - | -$5.20 M(-41.3%) | -$24.01 M(-7.9%) |
| Dec 2018 | -$26.08 M(+1743.0%) | -$8.85 M(+90.1%) | -$26.08 M(+51.4%) |
| Sept 2018 | - | -$4.66 M(-12.0%) | -$17.22 M(+37.1%) |
| June 2018 | - | -$5.29 M(-27.2%) | -$12.57 M(+72.8%) |
| Mar 2018 | - | -$7.27 M | -$7.27 M |
| Dec 2017 | -$1.42 M | - | - |
FAQ
- What is Bicycle Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly CFO year-on-year change?
- What is Bicycle Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM CFO year-on-year change?
What is Bicycle Therapeutics annual cash flow from operations?
The current annual CFO of BCYC is -$60.63 M
What is the all time high annual CFO for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual cash flow from operations is -$1.42 M
What is Bicycle Therapeutics quarterly cash flow from operations?
The current quarterly CFO of BCYC is -$39.83 M
What is the all time high quarterly CFO for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly cash flow from operations is $34.10 M
What is Bicycle Therapeutics quarterly CFO year-on-year change?
Over the past year, BCYC quarterly cash flow from operations has changed by +$7.46 M (+15.77%)
What is Bicycle Therapeutics TTM cash flow from operations?
The current TTM CFO of BCYC is -$202.62 M
What is the all time high TTM CFO for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM cash flow from operations is -$2.25 M
What is Bicycle Therapeutics TTM CFO year-on-year change?
Over the past year, BCYC TTM cash flow from operations has changed by -$141.99 M (-234.20%)